Kockdown of OIP5-AS1 expression inhibits proliferation, metastasis and EMT progress in hepatoblastoma cells through up-regulating miR-186a-5p and down-regulating ZEB1

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Ze ZhangYahui Liu

Abstract

Long non-coding RNA OIP5-AS1 has been studied in human diseases, including several kinds of cancers. It was not studied or reported in hepatoblastoma, so we chose it to do our research in hepatoblastoma. We thought OIP5-AS1 was oncogenic in hepatoblastoma for the high expression of it in hepatoblastoma tissues and cells. OIP5-AS1 knockdown was carried out in cancer cells. Unsurprisingly, this action was verified to be able to inhibit cell proliferation, metastasis and EMT progress in hepatoblastoma. We then measured the low expression level of miR-186a-5p and the high expression level of ZEB1 in hepatoblastoma tissues and cells. The relevance among them was analyzed by using correlation analysis. In order to prove the ceRNA pattern in this study, nuclear separation experiment, RIP assay and dual luciferase assays were all put into use. We discovered OIP5-AS1 is located in nucleus of cancerous cells. It could target to miR-186a-5p and up-regulate the target gene of miR-186a-5p (ZEB1). Finally, rescue assay was utilized and proved the effect of OIP5-AS1-miR-186a-5p-ZEB1 axis on hepatoblastoma cell activities. Based on all above findings, we came into a conclusion that OIP5-AS1 is a ceRNA in Hepatoblastoma cells through modulating...Continue Reading

References

Dec 8, 2000·The Oncologist·C E HerzogF Eftekhari
Jan 18, 2012·Seminars in Pediatric Surgery·Dietrich von Schweinitz
Jun 6, 2012·Annual Review of Biochemistry·John L Rinn, Howard Y Chang
Mar 14, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Dan XuShu-han Sun
May 11, 2013·British Journal of Cancer·S W CheethamM E Dinger
Dec 11, 2013·Current Opinion in Pediatrics·Piotr CzaudernaRebecka L Meyers
Jun 11, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Deshui JiaXianghuo He
Aug 20, 2014·Journal of Hepatology·Melanie EichenmüllerRoland Kappler
Jan 29, 2016·Nucleic Acids Research·Jiyoung KimMyriam Gorospe
May 5, 2017·Oncotarget·Jiyoung KimMyriam Gorospe
Sep 9, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Shanyi ZhangZhaoyu Lin
Sep 22, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Deyuan ZhangFanrong Liu
Sep 28, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Chenyang XuBingqian Ding
Nov 6, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Guangwei ZhangChaoyang Zhu
Dec 10, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Likun YanJian Qiu
Dec 17, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Jun DengSongping Wang
Jan 13, 2018·Journal of Cellular Physiology·Xing JiangJun-Li Xue

❮ Previous
Next ❯

Citations

Mar 27, 2019·Cancers·Ion CristóbalJesús García-Foncillas
Apr 21, 2019·International Journal of Molecular Sciences·Mila Gugnoni, Alessia Ciarrocchi
Sep 25, 2019·Cancers·Nirmala Mavila, Jyothi Thundimadathil
Mar 10, 2020·Acta Biochimica Et Biophysica Sinica·Rongjun XieYang Hu
Aug 5, 2020·International Journal of Molecular Sciences·Ana TorroglosaSalud Borrego
Nov 30, 2019·Frontiers in Cell and Developmental Biology·Xichun CuiGuangying Cui
Jan 7, 2021·RNA Biology·Elżbieta WanowskaMichał Wojciech Szcześniak
Sep 3, 2019·Clinica Chimica Acta; International Journal of Clinical Chemistry·Yuwei LiJunqing Han
Jan 29, 2021·Molecular Genetics and Genomics : MGG·Yanjun DingRuijie Zhang
Feb 19, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Soudeh Ghafouri-FardMohammad Taheri
Oct 12, 2021·Frontiers in Cardiovascular Medicine·Yuyao JiKang Yao
Aug 19, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Jian DaiXiaoming Tang
Jan 19, 2022·Clinical and Translational Medicine·Serena Wooten, Keriayn N Smith

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.